Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Testing effectiveness (Phase 2)Study completedNCT00006450What this trial is testingPhenylbutyrate to Treat Children With Progressive or Recurrent Brain TumorsWho this might be right forBrain Tumor National Cancer Institute (NCI) 120
Not applicableStudy completedNCT01789060What this trial is testingP-AKT Expression on Clinical Outcomes in Malignant LymphomaWho this might be right forMalignant LymphomaP13K-AKT Pathway Deregulation Samsung Medical Center 262
Testing effectiveness (Phase 2)UnknownNCT03792724What this trial is testingPhase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid TumorsWho this might be right forNeoplasms Clinica Universidad de Navarra, Universidad de Navarra 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07040280What this trial is testingTesting the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of MelanomaWho this might be right forMelanoma Eastern Cooperative Oncology Group 120
Early research (Phase 1)Study completedNCT00498979What this trial is testingSodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersWho this might be right forStage IV Melanoma Case Comprehensive Cancer Center 22
Early research (Phase 1)Looking for participantsNCT06958679What this trial is testingEvaluation of SYS6005 in Patients With Advanced Malignant TumorWho this might be right forB-cell MalignanciesSolid Tumors CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Very early researchEnded earlyNCT02653196What this trial is testingA Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid TumorsWho this might be right forNeuroepithelial TumorSolid TumorAllogeneic Hematopoietic Stem Cell Transplantation Montefiore Medical Center 1
Testing effectiveness (Phase 2)WithdrawnNCT04105062What this trial is testingLS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric SurgeryWho this might be right forPancreatic CancerLiver CancerGastric Cancer+2 more Washington University School of Medicine
Testing effectiveness (Phase 2)Study completedNCT01259869What this trial is testingPX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or ProgressionWho this might be right forGlioblastoma NCIC Clinical Trials Group 34
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more Exelixis 1,314
Very early researchUnknownNCT05459441What this trial is testingEfficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal MetastasesWho this might be right forGliomaBrain Metastases Shanghai Pudong Hospital 30
Not applicableStudy completedNCT00610415What this trial is testingBiopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility StudyWho this might be right forHead and Neck CancerHead and Neck Cancers Stanford University 40
Not applicableStudy completedNCT06960135What this trial is testingTrifecta Achievement in Open and Laparoscopic Partial NephrectomyWho this might be right forTrifecta AchievementPentafecta Achievement South Valley University 70
Early research (Phase 1)Looking for participantsNCT07007117What this trial is testingPHOX2B PC-CAR T Cells for Relapsed NeuroblastomaWho this might be right forRefractory NeuroblastomaRelapsed NeuroblastomaHigh-Risk Neuroblastoma Stephan Grupp MD PhD 38
Testing effectiveness (Phase 2)Ended earlyNCT01689974What this trial is testingPhase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic MelanomaWho this might be right forMetastatic Melanoma NYU Langone Health 10
Not applicableStudy completedNCT06856590What this trial is testingZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin ReactionWho this might be right forHand-Foot Skin Reaction (HFSR) Gazi University 150
Testing effectiveness (Phase 2)Ended earlyNCT00006113What this trial is testingVaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV MelanomaWho this might be right forMelanoma (Skin) University of Southern California 25
Not applicableUnknownNCT05547282What this trial is testingLow-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy FailureWho this might be right forCancer Patients Jiandong Zhang 20
Not applicableUnknownNCT04927260What this trial is testingFrench Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST PatientsWho this might be right forGISTGIST, MalignantPDGFR-Alpha D842V Centre Leon Berard 25